InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
T+90 hit rate
0%
T+90 mean return
-15.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Harris Todd, Chairman & CEO. Officer active across 1 company, notably Tyra Biosciences, Inc.. In total, 21 filings have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €2.9m. History available since 15 March 2022. The latest transaction was disclosed on 14 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations21 total
1,241 shares@ US$9.7750.4% of flowCommon StockSEC:0000950170-25-041551:0
43,636 shares@ US$27.014335.9% of flowCommon StockSEC:0000950170-24-116345:0
10,035 shares@ US$24.31197.4% of flowCommon StockSEC:0000950170-24-115432:0
500 shares@ US$24.000.4% of flowCommon StockSEC:0000950170-24-111702:0
10,092 shares@ US$24.12577.2% of flowCommon StockSEC:0000950170-24-109410:0
3,500 shares@ US$24.002.5% of flowCommon StockSEC:0000950170-24-108533:0
1,350 shares@ US$6.5790.3% of flowCommon StockSEC:0000950170-24-107399:0
1,880 shares@ US$6.5790.4% of flowCommon StockSEC:0000950170-24-033814:0
78,996 shares@ US$16.445939.4% of flowCommon StockSEC:0000950170-24-011879:0
1,421 shares@ US$6.5794.6% of flowCommon StockSEC:0001209191-23-050092:0
2,978 shares@ US$16.97721.5% of flowCommon StockSEC:0001209191-23-039807:0
3,316 shares@ US$16.491.6% of flowCommon StockSEC:0001209191-23-038945:0
7,927 shares@ US$2.250.5% of flowCommon StockSEC:0001209191-23-037613:0
2,000 shares@ US$2.250.1% of flowCommon StockSEC:0001209191-23-023402:0
1,420 shares@ US$2.250.1% of flowCommon StockSEC:0001209191-23-021947:0
170 shares@ US$2.250.0% of flowCommon StockSEC:0001209191-23-021443:0
12,393 shares@ US$2.250.9% of flowCommon StockSEC:0001209191-23-020848:0
1,808 shares@ US$6.5790.4% of flowCommon StockSEC:0001209191-23-019793:0
3,125 shares@ US$8.52550.8% of flowCommon StockSEC:0001209191-22-049213:0
34,007 sharesCommon StockSEC:0000899243-21-036426:0
34,007 sharesCommon StockSEC:0000899243-21-036426
21 of 21 declarations
About Harris Todd
Todd Harris is the Chief Executive Officer of Tyra Biosciences, Inc. He leads the company in developing innovative biopharmaceutical solutions. His leadership is essential in guiding Tyra through a constantly evolving sector.
